![]() |
Volumn 69, Issue 5, 2000, Pages 569-571
|
Progressive multifocal leucoencephalopathy: Progress in the AIDS era
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
CD4 ANTIGEN;
CIDOFOVIR;
CYTARABINE;
IMMUNOGLOBULIN G ANTIBODY;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS DNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL FEATURE;
CLINICAL TRIAL;
CYTOMEGALOVIRUS INFECTION;
DEPRESSION;
DIAGNOSTIC ACCURACY;
EDITORIAL;
FATIGUE;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
IATROGENIC DISEASE;
INCIDENCE;
JC VIRUS;
LEUKOPENIA;
MORTALITY;
MYCOBACTERIOSIS;
PANCYTOPENIA;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RISK FACTOR;
SURVIVAL RATE;
VERRUCA VULGARIS;
|
EID: 0033789878
PISSN: 00223050
EISSN: None
Source Type: Journal
DOI: 10.1136/jnnp.69.5.569 Document Type: Editorial |
Times cited : (32)
|
References (23)
|